for a world without blood cancer
Who would dare to pit one fatal disease against another... inside the body of an six-year-old patient? The results will shatter all expectations.
P.S. We have danced with Emma!
LLS celebrates physician-researcher Brian Druker, MD, director of OHSU Knight Cancer Institute, professor of medicine, and pioneer of breakthrough therapies for blood cancer patients
President & CEO Louis DeGennaro talks about delivering results and how their research has helped discover virtually every therapy currently used to treat blood cancers.
For The Leukemia & Lymphoma Society (LLS), now is the most momentous time in cancer research. LLS's mission is to cure leukemia, lymphoma, Hodgkin's disease and myeloma, and improve the quality of life of patients and their families - here is living proof that we are making someday, today